Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-076174
Filing Date
2023-03-22
Accepted
2023-03-22 06:06:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d480258d424b5.htm 424B5 4869
2 GRAPHIC g480258g0322073403010.jpg GRAPHIC 2325
  Complete submission text file 0001193125-23-076174.txt   9551
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

EIN.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261342 | Film No.: 23751192
SIC: 2834 Pharmaceutical Preparations